Enveda biosciences announces microsoft collaboration and reveals foundation model to “read and translate” chemistry

Boulder, colo.--(business wire)--enveda biosciences (“enveda”), a biotechnology company using ai to translate nature into new medicines, announced today a new collaboration with microsoft and released details on their work creating their foundation model, called prism, trained on the world's largest collection of experimental mass spectra. the announced initiatives support enveda's continued leadership in natural product drug discovery and its evolution into a clinical-stage company. the collab.
MSFT Ratings Summary
MSFT Quant Ranking